Susquehanna International Group, LLP Zynerba Pharmaceuticals, Inc. Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

21 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	SELL	$0.5 - $0.72 $1,250 - $1,800	-2,500 Reduced 9.43%	24,000 $12,000
Q3 2022 Nov 14, 2022	BUY	$0.87 - $1.36 $957 - $1,496	1,100 Added 4.33%	26,500 $19,000
Q2 2022 Aug 15, 2022	SELL	$0.86 - $2.06 $2,064 - $4,944	-2,400 Reduced 8.63%	25,400 $29,000
Q1 2022 May 16, 2022	SELL	$1.83 - $3.02 $34,953 - $57,682	-19,100 Reduced 40.72%	27,800 $57,000
Q4 2021 Feb 14, 2022	SELL	$2.88 - $4.3 $446,112 - $666,070	-154,900 Reduced 76.76%	46,900 $135,000
Q3 2021 Nov 15, 2021	SELL	$3.72 - $5.35 $570,276 - $820,155	-153,300 Reduced 43.17%	201,800 $856,000
Q2 2021 Aug 11, 2021	SELL	$3.83 - $5.98 $834,174 - $1.3 Million	-217,800 Reduced 38.02%	355,100 $1.88 Million
Q1 2021 May 17, 2021	BUY	$3.33 - $8.76 $1.23 Million - $3.23 Million	369,200 Added 181.25%	572,900 $2.66 Million
Q4 2020 Feb 16, 2021	BUY	$3.27 - $4.64 $59,514 - $84,448	18,200 Added 9.81%	203,700 $672,000
Q3 2020 Nov 16, 2020	SELL	$3.23 - $4.3 $248,710 - $331,100	-77,000 Reduced 29.33%	185,500 $614,000
Q2 2020 Aug 14, 2020	BUY	$3.31 - $6.54 $458,435 - $905,790	138,500 Added 111.69%	262,500 $885,000
Q1 2020 May 15, 2020	SELL	$2.9 - $6.16 $238,670 - $506,968	-82,300 Reduced 39.89%	124,000 $475,000
Q4 2019 Feb 14, 2020	SELL	$5.61 - $8.57 $539,682 - $824,434	-96,200 Reduced 31.8%	206,300 $1.25 Million
Q3 2019 Nov 14, 2019	SELL	$7.56 - $15.44 $3.4 Million - $6.94 Million	-449,500 Reduced 59.77%	302,500 $2.29 Million
Q2 2019 Aug 14, 2019	BUY	$5.4 - $15.5 $3.62 Million - $10.4 Million	670,200 Added 819.32%	752,000 $10.2 Million
Q1 2019 May 15, 2019	BUY	$3.6 - $6.22 $127,080 - $219,566	35,300 Added 75.91%	81,800 $443,000
Q3 2018 Nov 14, 2018	SELL	$5.59 - $10.45 $19,565 - $36,575	-3,500 Reduced 7.0%	46,500 $379,000
Q2 2018 Aug 14, 2018	BUY	$7.98 - $12.39 $199,500 - $309,750	25,000 Added 100.0%	50,000 $487,000
Q1 2018 May 15, 2018	SELL	$8.49 - $13.46 $336,204 - $533,016	-39,600 Reduced 61.3%	25,000 $217,000
Q4 2017 Feb 14, 2018	SELL	$8.69 - $14.59 $3.68 Million - $6.18 Million	-423,800 Reduced 86.77%	64,600 $809,000
Q3 2017 Nov 14, 2017	BUY	$5.73 - $9.44 $2.8 Million - $4.61 Million	488,400	488,400 $4.08 Million

Others Institutions Holding ZYNE

# of Institutions

Shares Held

774K

Call Options Held

Put Options Held

View Full List

About Zynerba Pharmaceuticals, Inc.

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

More about ZYNE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account